44 related articles for article (PubMed ID: 38474579)
1. Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-
Elsenbawy ESM; Alshehri ZS; Babteen NA; Abdel-Rahman AA; El-Manawaty MA; Nossier ES; Arafa RK; Hassan NA
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474579
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
3. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.
Lauria A; Patella C; Abbate I; Martorana A; Almerico AM
Eur J Med Chem; 2013 Jul; 65():381-8. PubMed ID: 23747807
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
5. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
6. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM
Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722
[TBL] [Abstract][Full Text] [Related]
7. New pyrazolopyridine and pyrazolothiazole-based compounds as anti-proliferative agents targeting c-Met kinase inhibition: design, synthesis, biological evaluation, and computational studies.
Alamshany ZM; Algamdi EM; Othman IMM; Anwar MM; Nossier ES
RSC Adv; 2023 Apr; 13(19):12889-12905. PubMed ID: 37114032
[TBL] [Abstract][Full Text] [Related]
8. New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation.
El-Sayed WA; Alminderej FM; Mounier MM; Nossier ES; Saleh SM; F Kassem A
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080455
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers.
Elzahabi HSA; Nossier ES; Alasfoury RA; El-Manawaty M; Sayed SM; Elkaeed EB; Metwaly AM; Hagras M; Eissa IH
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1053-1076. PubMed ID: 35821615
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new derivatives of thieno-thiazole and dihydrothiazolo-thiazole scaffolds integrated with a pyrazoline nucleus as anticancer and multi-targeting kinase inhibitors.
Othman IMM; Alamshany ZM; Tashkandi NY; Gad-Elkareem MAM; Abd El-Karim SS; Nossier ES
RSC Adv; 2021 Dec; 12(1):561-577. PubMed ID: 35424523
[TBL] [Abstract][Full Text] [Related]
11. New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFR
Hashem HE; Amr AEE; Nossier ES; Anwar MM; Azmy EM
ACS Omega; 2022 Mar; 7(8):7155-7171. PubMed ID: 35252706
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new thieno[2,3-
Elmenier FM; Lasheen DS; Abouzid KAM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):315-332. PubMed ID: 34955086
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M
Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
